Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases
The Special Issue of Biomedicines, entitled "Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases," presents cutting-edge research findings, innovations, and insights into a wide range of topics related to the hepatobiliary system, such as the molecular mechanisms underlying...
| Format: | eBook |
|---|---|
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
| LEADER | 03678namaa2201045uu 4500 | ||
|---|---|---|---|
| 001 | doab100886 | ||
| 003 | oapen | ||
| 005 | 20230623 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 230623s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a 9783036577388 | ||
| 020 | |a 9783036577395 | ||
| 020 | |a books978-3-0365-7738-8 | ||
| 024 | 7 | |a 10.3390/books978-3-0365-7738-8 |2 doi | |
| 040 | |a oapen |c oapen | ||
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 720 | 1 | |a Wang, Jinghua |4 edt | |
| 720 | 1 | |a Wang, Jinghua |4 oth | |
| 245 | 0 | 0 | |a Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 online resource (190 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
| 520 | |a The Special Issue of Biomedicines, entitled "Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases," presents cutting-edge research findings, innovations, and insights into a wide range of topics related to the hepatobiliary system, such as the molecular mechanisms underlying disease pathogenesis, diagnostic advancements, novel therapeutic approaches, and prevention strategies. The Special Issue comprises seven original articles and four review articles regarding NAFLD, primary biliary cholangitis (PBC), hepatitis B and C, and hepatocellular carcinoma (HCC). | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a AAV | ||
| 653 | |a autoantibodies | ||
| 653 | |a biomarker | ||
| 653 | |a budesonide | ||
| 653 | |a cholestatic diseases | ||
| 653 | |a chronic hepatitis B | ||
| 653 | |a cirrhosis | ||
| 653 | |a DAA | ||
| 653 | |a deletions | ||
| 653 | |a farnesoid X receptor | ||
| 653 | |a fatty liver | ||
| 653 | |a females | ||
| 653 | |a fibrates | ||
| 653 | |a fibrosis score | ||
| 653 | |a FXR agonists | ||
| 653 | |a gender | ||
| 653 | |a gene therapy | ||
| 653 | |a genotoxicity | ||
| 653 | |a glycoprotein gp210 | ||
| 653 | |a HBX 3' end region | ||
| 653 | |a HCV | ||
| 653 | |a hepatic steatosis | ||
| 653 | |a hepatitis B virus | ||
| 653 | |a hepatitis B X open reading frame | ||
| 653 | |a hepatocellular carcinoma | ||
| 653 | |a insertions | ||
| 653 | |a KLHL12 peptide | ||
| 653 | |a liver | ||
| 653 | |a liver fibrosis | ||
| 653 | |a metabolism | ||
| 653 | |a miR-125b | ||
| 653 | |a mitochondria | ||
| 653 | |a n/a | ||
| 653 | |a NAFLD | ||
| 653 | |a NASH | ||
| 653 | |a next-generation sequencing | ||
| 653 | |a non-alcoholic fatty liver disease | ||
| 653 | |a nucleoporin p62 | ||
| 653 | |a nucleos(t)ide analogs | ||
| 653 | |a obeticholic acid | ||
| 653 | |a obeticholic acid (OCA) | ||
| 653 | |a PBC | ||
| 653 | |a PFIC | ||
| 653 | |a PPAR agonists | ||
| 653 | |a primary biliary cholangitis | ||
| 653 | |a quasispecies | ||
| 653 | |a radiofrequency ablation | ||
| 653 | |a RUNX1 | ||
| 653 | |a side effect | ||
| 653 | |a systems biology | ||
| 653 | |a transarterial chemoembolization | ||
| 653 | |a transient hepatic elastography | ||
| 653 | |a type 2 diabetes mellitus | ||
| 653 | |a ursodeoxycholic acid | ||
| 653 | |a ursodeoxycholic acid (UDCA) | ||
| 793 | 0 | |a DOAB Library. | |
| 856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/100886 |7 0 |z Open Access: DOAB: description of the publication |
| 856 | 4 | 0 | |u https://mdpi.com/books/pdfview/book/7351 |7 0 |z Open Access: DOAB, download the publication |